Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2395 Target Snapshot

Purine nucleoside phosphorylase · SINGLE PROTEIN · Rattus norvegicus

34Compounds
7Assays
0Approved Drugs
42.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P85973. Use UniProt P85973 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P85973 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Purine nucleoside phosphorylase as ChEMBL target CHEMBL2395, mapped to UniProt P85973. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Purine nucleoside phosphorylase
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2395
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P85973
Purine nucleoside phosphorylase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Purine nucleoside phosphorylase is the right protein anchor across sources, using UniProt P85973 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPurine nucleoside phosphorylase
UniProt AccessionP85973
Component TypeProtein
Sequence Length289 aa

Purine nucleoside phosphorylase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Purine nucleoside phosphorylase, mapped to UniProt P85973. Sequence length is 289 aa.

Mapped IDP85973
Review namePurine nucleoside phosphorylase
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC5026.0
KI16.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL315570 8.0 IC50 10.0 Preclinical
CHEMBL81839 7.96 IC50 11.0 Preclinical
CHEMBL311300 7.6 IC50 25.0 Clinical
CHEMBL79784 7.6 IC50 25.0 Preclinical
CHEMBL81348 7.55 IC50 28.0 Preclinical
CHEMBL310458 7.54 IC50 29.0 Preclinical
CHEMBL56593 7.54 IC50 29.0 Preclinical
CHEMBL81055 7.46 IC50 35.0 Preclinical
CHEMBL83053 7.4 IC50 40.0 Preclinical
CHEMBL13448 7.36 IC50 44.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
1
5.5
1
6.0
6
6.5
6
7.0
6
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

7
Total Assays
29
Tested Compounds
1
Assay Types
Binding — 7 assays, 29 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 4 29 6.4
single protein format 3 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine